Neogenomics Inc expected to post a loss of 5 cents a share - Earnings Preview

NeoGenomics

26/04/2024 14:37

* Neogenomics Inc  NEO.OQ   NEO.O  is expected to show a
rise in
quarterly revenue when it reports  results on April 30 for the
period ending March 31 2024
    * The Fort Myers Florida-based  company is expected to
report a
9.2% increase in revenue to $149.889 million from $137.22
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.The company's guidance on February
20 2024, for the period ended March 31, was for revenue between
$148.00 million and $151.00 million.
    * ​LSEG's mean analyst estimate for Neogenomics Inc is for a
loss
of 5 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 21.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Neogenomics
Inc
is $20.00​, above​ its last closing price of $13.85. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.01       -0.02      0.03      Beat    220.4
 Sep. 30 2023  -0.06       -0.07      0.00      Beat    100
 Jun. 30 2023  -0.11       -0.11      -0.05     Beat    56​
 Mar. 31 2023  -0.15       -0.15      -0.09     Beat    40.5
 ​​Dec.        -0.15       -0.16      -0.06     Beat    63.6
 31 2022                                                
 Sep. 30 2022  -0.20       -0.21      -0.14     Beat    32​
 Jun. 30 2022  -0.20       -0.23      -0.16     Beat    29
 Mar. 31 2022  -0.24       -0.24      -0.20     Beat    15
 This summary was machine generated April 26 at 13:37 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)